scholarly article | Q13442814 |
P2093 | author name string | Wen-Ming Hsu | |
Ji-Shiang Hung | |||
Jin-Tung Liang | |||
Hong-Shiee Lai | |||
Min-Chuan Huang | |||
John Huang | |||
Mei-Ieng Che | |||
Miao-Juei Huang | |||
Yo-Chuen Lin | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N'-diacetyllactosediamine, galNAc beta 1-4GlcNAc | Q24321810 | ||
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer | Q27851456 | ||
Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 | ||
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells | Q28264780 | ||
Structural Analysis of the Oligosaccharides Derived from Glycodelin, a Human Glycoprotein with Potent Immunosuppressive and Contraceptive Activities | Q28291747 | ||
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states | Q33186313 | ||
N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin | Q33732475 | ||
Angiogenic role for glycodelin in tumorigenesis | Q33930637 | ||
Understanding resistance to EGFR inhibitors-impact on future treatment strategies | Q34088424 | ||
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. | Q34398347 | ||
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer | Q34421001 | ||
The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation. | Q34689170 | ||
Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor | Q35539734 | ||
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells | Q35626139 | ||
Derivation, propagation and differentiation of human embryonic stem cells | Q35686351 | ||
Isolation, propagation, and characterization of rat liver serosal mesothelial cells. | Q35834276 | ||
Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4 | Q36217283 | ||
Molecular basis for protein-specific transfer of N-acetylgalactosamine to N-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4. | Q36217425 | ||
Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells | Q36347787 | ||
Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis | Q37154050 | ||
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma | Q37316834 | ||
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. | Q37360712 | ||
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis | Q37420167 | ||
Colon cancer stem cells: promise of targeted therapy. | Q37737414 | ||
Characterisation of insulin-like growth factor receptors and insulin receptors in the human placenta using lectin affinity methods | Q38312878 | ||
Apical Golgi localization of N,N'-diacetyllactosediamine synthase, beta4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosa | Q38312893 | ||
c-Met function requires N-linked glycosylation modification of pro-Met | Q39260851 | ||
Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor | Q39459644 | ||
A necessary and sufficient determinant for protein-selective glycosylation in vivo | Q40042570 | ||
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells | Q40117775 | ||
A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator | Q41693783 | ||
Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies. | Q46384821 | ||
N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion. | Q46883768 | ||
LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling. | Q54388643 | ||
Colon cancer | Q57758148 | ||
Isolation and Culture of Colon Cancer Stem Cells | Q60684263 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colon cancer | Q18555025 |
P304 | page(s) | 3673-3684 | |
P577 | publication date | 2014-06-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells | |
P478 | volume | 5 |
Q37565255 | Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC). |
Q92402595 | Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection |
Q45852537 | Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer |
Q58776125 | Extracellular galectin-3 facilitates colon cancer cell migration and is related to the epidermal growth factor receptor |
Q41124448 | Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway |
Q55639950 | Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. |
Q64166945 | Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands |
Q92537294 | Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2 |
Q37405898 | Integrated glycomic analysis of ovarian cancer side population cells |
Q90673235 | LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells |
Q27728015 | Molecular basis for recognition of the cancer glycobiomarker LacdiNAc (GalNAc(β1-4)GlcNAc) by Wisteria floribunda agglutinin |
Q41171796 | New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma |
Q59327036 | Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells |
Q36182285 | Protein O-Mannosylation in the Murine Brain: Occurrence of Mono-O-Mannosyl Glycans and Identification of New Substrates |
Q28069952 | Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma |
Q38510649 | The "next-generation" knowledge of papillary thyroid carcinoma |
Q39757304 | The directed migration of gonadal distal tip cells in Caenorhabditis elegans requires NGAT-1, a ß1,4-N-acetylgalactosaminyltransferase enzyme. |
Q37713999 | The lactoferricin B-derived peptide, LfB17-34, induces melanogenesis in B16F10 cells |
Q26779166 | The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications |
Q35247136 | Trefoil factor family domains represent highly efficient conformational determinants for N-linked N,N'-di-N-acetyllactosediamine (LacdiNAc) synthesis |
Search more.